Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

6 Companies to Invest in Today for 10 Years of Growth

By Chris Markoch, InvestorPlace Contributor

What a difference 10 weeks has made in the stock market. So which companies should you invest in for the next 10 years? Here are 6 choices.

It’s Not a Fantasy to Believe in DraftKings

By Chris Markoch, InvestorPlace Contributor

With live sporting events returning, even without fans, the games themselves represent a viable opportunity for DraftKings stock.

For United Airlines, Less Bad Is the New Good

By Chris Markoch, InvestorPlace Contributor

Airline-based investments like UAL stock may make a solid long-term investment. But for now, consumer fears make this market a tough one to negotiate.

What to Expect From Momo Earnings

By Chris Markoch, InvestorPlace Contributor

Sentiment in Momo stock is lukewarm heading into earnings on May 28. Investors will want to see growth return after the Covid-19 pandemic.

SPXL’s Allure of S&P 500 Outperformance is Too Risky for the Near-Term

By Chris Markoch, InvestorPlace Contributor

The SPXL stock was a top performer in the recent bull market. But there are reasons beyond the virus to avoid this 3X ETF for the long term.

Load More